SCHEMBL7974850

SCHEMBL7974850

O=c1[nH]c(-c2ccccc2Cl)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.56
ALDH1A1 P00352 3/20 0.56
KMT2A Q03164 2/20 0.55
HPGD P15428 1/20 0.53
GUSB P08236 1/20 0.49
DPP4 P27487 1/20 0.46
ACP1 P24666 1/20 0.44
PARN O95453 1/20 0.44
CNOT7 Q9UIV1 1/20 0.44
PNP P00491 1/20 0.44
CXCR2 P25025 1/20 0.43
GAA P10253 1/20 0.43
BRD4 O60885 1/20 0.43
KDM4E B2RXH2 1/20 0.42
PTGES O14684 3/20 0.42
CYP2C9 P11712 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985798 0.89 GUSB (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDGUSB
SCHEMBL7985535 0.87 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1KMT2AHPGDGUSB
SCHEMBL7974644 0.87 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1KMT2AHPGDACP1
SCHEMBL7975265 0.85 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1KMT2AHPGDPARN
SCHEMBL7975119 0.84 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDGUSB
SCHEMBL7984453 0.83 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDGUSB
SCHEMBL7974857 0.81 CNOT7 (0.52) SMN1; SMN2ALDH1A1KMT2AHPGDGUSB
SCHEMBL7975129 0.81 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDPARN
SCHEMBL7974445 0.81 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDPARN
SCHEMBL7985490 0.81 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDPARN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed